7 completed, 1 recruiting, 1 unknown. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 7, Recruiting 1, Unknown 1 |
Follow Lexiscan: new trials by email Literature Review of Lexiscan trials Research Report on Lexiscan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allograft Dysfunction in Heart Transplant Regadenoson - Heart Transplant Failure and Rejection | Phase 4 | Recruiting | Paul Kim | 376 | 2019-10-01 | 2026-05-01 |
| Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction Regadenoson, Gadolinium, Cardiac MRI - Heart Transplant, Acute Graft Rejection | Phase 4 | Completed | Paul Kim | 14 | 2015-11-01 | 2017-08-22 |
| Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging Regadenoson - Coronary Artery Disease | Phase 4 | Completed | Timothy M. Bateman | 40 | 2014-09-03 | 2018-09-19 |
| Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation Regadenoson, Rubidium-82 - Myocardial Blood Flow Reserve | Phase 4 | Completed | Timothy M. Bateman, MD | 80 | 2013-07-01 | 2018-08-16 |
| Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson Regadenoson - Ischemic Heart Disease | Phase 4 | Completed | Washington University School of Medicine | 16 | 2013-01-01 | 2018-06-15 |
| Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease regadenoson - Coronary Artery Disease | Phase 4 | Unknown | Dipan Shah | 50 | 2011-08-01 | 2017-10-03 |
| Stress Testing and Cardiac Magnetic Resonance regadenoson - Coronary Disease | Phase 4 | Completed | University of Chicago | 20 | 2009-04-01 | 2021-07-12 |
| A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment Regadenoson, Placebo - Kidney Diseases, Coronary Artery Disease | Phase 4 | Completed | Astellas Pharma Inc | 511 | 2009-04-01 | 2012-05-18 |
| A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease Regadenoson, Placebo - Asthma, Coronary Artery Disease | Phase 4 | Completed | Astellas Pharma Inc | 1009 | 2009-04-01 | 2012-09-18 |
Coronary Artery Disease (4) · Asthma (1) · Coronary Disease (1) · Kidney Diseases (1) · Myocardial Ischemia (1) · Pulmonary Disease, Chronic Obstructive (1) · Rejection, Psychology (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Astellas Pharma Inc (2) · Paul Kim (2) · Dipan Shah (1) · Timothy M. Bateman (1) · Timothy M. Bateman, MD (1) · University of Chicago (1) · Washington University School of Medicine (1)
United States (9)
Timothy M Bateman, MD (2) · Amit Patel, M.D. (1) · Dipan Shah, M.D. (1) · Pamela K Woodard, MD, BA (1) · Paul J Kim, MD (1) · Paul Kim, MD (1)
PMID 11693758, PMID 11943259, PMID 16890123, PMID 18551063, PMID 19284612, PMID 20413602, PMID 20643330, PMID 21555100, PMID 21962016, PMID 22484721, PMID 23272658, PMID 24355800, PMID 24457279, PMID 3308166